Intercept Pharmaceuticals, Inc.

Russell Investments Group, Ltd.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/10/2023

Shares

61,075

Value ($000)

675

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/10/2023	675	0.0%	61,075	6/30/2023
2023 Q1	5/9/2023	991	0.0%	73,806	3/31/2023
2022 Q4	2/8/2023	763	0.0%	61,668	12/31/2022
2022 Q3	11/4/2022	760	0.0%	54,603	9/30/2022
2022 Q2	7/29/2022	674	0.0%	48,886	6/30/2022
2022 Q1	5/5/2022	867	0.0%	53,385	3/31/2022
2021 Q4	1/21/2022	1,120	0.0%	68,845	12/31/2021
2021 Q3	11/8/2021	1,143	0.0%	77,037	9/30/2021
2021 Q2	8/4/2021	1,587	0.0%	79,483	6/30/2021
2021 Q1	5/10/2021	1,157	0.0%	50,206	3/31/2021
2020 Q4	2/8/2021	2,998	0.0%	121,441	12/31/2020
2020 Q3	11/9/2020	7,639	0.0%	184,213	9/30/2020
2020 Q2	8/5/2020	2,006	0.0%	41,903	6/30/2020
2020 Q1	5/6/2020	1,249	0.0%	19,860	3/31/2020
2019 Q4	1/29/2020	2,546	0.0%	20,561	12/31/2019